Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: J Allergy Clin Immunol. 2019 Jan 14;143(4):1465–1473. doi: 10.1016/j.jaci.2018.12.1003

TABLE V.

Most frequently reported vaccines administered alone among reports of anaphylaxis, by age group

Vaccine <4 y (%),
n = 37		 4–10 y (%),
n = 90		 11–18 y (%),
n = 40		 19–49 y (%),
n = 201		 ≥50 y (%),
n = 99		 Total (%),
n = 467
Influenza, all types 16 (43) 30 (33) 13 (33) 132 (66) 63 (64) 254 (54)
Varicella 7 (19) 29 (32) 0 (0) 2 (1) 1 (1) 39 (8)
Hepatitis B 2 (5) 1 (1) 2 (5) 24 (12) 4 (4) 33 (7)
MMR 3 (8) 18 (20) 5 (13) 4 (2) 0 (0) 30 (6)
DTaP/Tdap 1 (3) 3 (3) 4 (10) 14 (7) 3 (3) 25 (5)
PPVS23 0 (0) 5 (6) 2 (5) 3 (1) 11 (11) 21 (5)
Herpes zoster, live 0 (0) 0 (0) 0 (0) 0 (0) 12 (12) 12 (3)
4vHPV 0 (0) 0 (0) 6 (15) 3 (1) 0 (0) 9 (2)

DTaP/Tdap, Combined diphtheria and tetanus toxoids and acellular pertussis vaccine; PPVS23, pneumococcal polysaccharide vaccine.